403 related articles for article (PubMed ID: 7540592)
1. Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.
Rajnavölgyi E; Fazekas G; Lund J; Daeron M; Teillaud JL; Jefferis R; Fridman WH; Gergely J
Immunology; 1995 Apr; 84(4):645-52. PubMed ID: 7540592
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of IgG2a-reactive autoantibodies from influenza virus-infected BALB/c mice.
Fazekas G; Rajnavölgyi E; Kurucz I; Sintár E; Kiss K; László G; Gergely J
Eur J Immunol; 1990 Dec; 20(12):2719-29. PubMed ID: 2269331
[TBL] [Abstract][Full Text] [Related]
3. Specificity and molecular characteristics of monoclonal IgM rheumatoid factors from arthritic and non-arthritic mice.
Aguado MT; Balderas RS; Rubin RL; Duchosal MA; Kofler R; Birshtein BK; Secher DS; Dixon FJ; Theofilopoulos AN
J Immunol; 1987 Aug; 139(4):1080-7. PubMed ID: 2440945
[TBL] [Abstract][Full Text] [Related]
4. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors.
Bonagura VR; Artandi SE; Davidson A; Randen I; Agostino N; Thompson K; Natvig JB; Morrison SL
J Immunol; 1993 Oct; 151(7):3840-52. PubMed ID: 7690818
[TBL] [Abstract][Full Text] [Related]
5. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.
Pluschke G; Bordmann G; Daoudaki ME; Lambris JD; Achtman M; Neibert M
Eur J Immunol; 1989 Jan; 19(1):131-5. PubMed ID: 2646134
[TBL] [Abstract][Full Text] [Related]
6. The isotype and specificity of antiglobulins in BALB/c mice.
Jones MG; Hay FC
Clin Exp Immunol; 1985 Feb; 59(2):475-81. PubMed ID: 3872191
[TBL] [Abstract][Full Text] [Related]
7. Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodies.
Lohse S; Peipp M; Beyer T; Valerius T; Dechant M
Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):303-12. PubMed ID: 20508996
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
Russell MW; Reinholdt J; Kilian M
Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
[TBL] [Abstract][Full Text] [Related]
9. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
Miletic VD; Hester CG; Frank MM
J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
[TBL] [Abstract][Full Text] [Related]
10. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
11. Complement activation is not required for IgG-mediated suppression of the antibody response.
Heyman B; Wiersma E; Nose M
Eur J Immunol; 1988 Nov; 18(11):1739-43. PubMed ID: 3060362
[TBL] [Abstract][Full Text] [Related]
12. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
[TBL] [Abstract][Full Text] [Related]
13. Complement activation by immunoglobulin does not depend solely on C1q binding.
Bindon CI; Hale G; Waldmann H
Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in rheumatoid factor isotypes and specificities in MRL mice.
Bond A; Cooke A; Hay FC
Immunology; 1988 May; 64(1):17-21. PubMed ID: 3384451
[TBL] [Abstract][Full Text] [Related]
15. Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors.
Ierino FL; Hulett MD; McKenzie IF; Hogarth PM
J Immunol; 1993 Mar; 150(5):1794-803. PubMed ID: 7679695
[TBL] [Abstract][Full Text] [Related]
16. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
Morgan A; Jones ND; Nesbitt AM; Chaplin L; Bodmer MW; Emtage JS
Immunology; 1995 Oct; 86(2):319-24. PubMed ID: 7490135
[TBL] [Abstract][Full Text] [Related]
17. Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions.
Sung SS
J Immunol; 1985 Sep; 135(3):1981-6. PubMed ID: 4020136
[TBL] [Abstract][Full Text] [Related]
18. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
Schlesinger JJ; Foltzer M; Chapman S
Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo.
Drebin JA; Link VC; Greene MI
Oncogene; 1988 Apr; 2(4):387-94. PubMed ID: 2896329
[TBL] [Abstract][Full Text] [Related]
20. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
